Compare UDR Inc. Common Stock (UDR) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UDR Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? UDR Inc. Common Stock trades at $33.9 (market cap $10.93B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: UDR Inc. Common Stock is far larger — about 6.1× Vir Biotechnology Inc. Common Stock's market cap, and UDR Inc. Common Stock pays a 5.12% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold UDR Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| UDR | VIR | |
|---|---|---|
Market Cap | $10.93B | $1.80B |
Volume | 2,607,837 | 1,782,836 |
Sector | Real Estate | Health |
52-Week High | $41.24 | $11.78 |
52-Week Low | $33.27 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $16.96B | $1.36B |
Dividend Yield | 5.12% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About UDR Inc. Common Stock
UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
